Abacavir Base (CAS number 188062-50-2) is a significant antiviral primarily utilized in the treatment of HIV disease and related secondary illnesses . It functions as a nucleoside blocker , interfering with the pathogen's duplication process . Administered often in alongside other AIDS drugs , abacavir has a key role in suppressing the amount of virus and improving person's health . Careful human leukocyte screening for the HLA-B*57:01 allele is essential prior to start of this regimen to avoid the possibility of a severe adverse effect.
Abarelix (183552-38-7): Attributes and Functions
Abarelix, identified by the Substance Designation 183552-38-7, is a synthetic polypeptide agonist of gonadotropin-releasing hormone (GnRH). The key feature lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a significant lessening in gonadotropin production . Medically , abarelix is utilized primarily in the treatment of advanced prostate cancer ; however, research also explores emerging roles in other hormonal disorders and reproductive health . The substance 's composition allows for selective receptor connection.
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The synthetic of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves intricate multistep laboratory routes. Several published methods exist, often beginning with Androstadienedione and utilizing specific oxidation and reaction steps. A typical procedure includes protecting group strategies to ensure intended regioselectivity. Analytical results, crucial for purity control, routinely employs liquid chromatography (HPLC) for quantification of purity. Nuclear Magnetic Resonance (NMR) analysis confirms the molecular identity. Mass spectrometry supplies molecular weight confirmation. Other methods, like infrared (IR) analysis, assist in identification and are essential for lot release.
- Synthesis Routes
- Purity Control
- Analytical Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Knowing these identifiers aids in accurate referencing and prevents ambiguity within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone Acetate a CYP17 inhibitor used in metastatic ACECLOFENAC 89796-99-6 prostate cancer, possesses the CAS number 857342-50-7. Precisely utilizing these numbers ensures clarity and consistency when discussing these medications.
- Compound A CAS Number: 60242-78-0
- Abarelix CAS Number: 5490-02-9
- Compound C CAS Number: 857342-50-7
```
Key Information on Abacavir , Abarelix , and Abiraterone
These medications represent distinct solutions in medicine. Abacavir is a nucleoside reverse transcriptase inhibitor primarily given to treat HIV disease , often with other antiviral . Abarelix for Treatment is a drug that functions as a hormone blocker , typically prescribed to lower prostate cancer before removal. Lastly, Abiraterone Drug is another therapy given to treat advanced prostate malignancies , specifically suppressing testosterone creation. Always remember consult a doctor for complete information and guidance regarding any prescription .
Drug Insights: Abacavir Salt, Abarelix, Abiraterone and Their Chemical Abstracts Service Numbers
Examining various medicinal medications necessitates a clear determination. Notably, Abacavir Sulfate, used in HIV therapy, has a Chemical Abstracts Service Number of 3870-92-6. In the same way, Abarelix, an hormone blocker administered during testicular cancer management, bears the Registration Number 64347-82-2. Finally, Abiraterone Acetate, a medication in aggressive testicular tumors, is identified with the CAS Number 864930-63-3. These identifiers are vital resources in accurate drug referencing & research.